Labiotech.eu

News and Trends 27 Mar 2020

Evox Therapeutics Receives up to €800M from Takeda To Tackle Rare Diseases

The Japanese pharmaceutical company Takeda has struck a deal worth up to €803M with UK biotech Evox Therapeutics to develop rare disease treatments delivered to cells via nanocapsules called exosomes. As part of the deal, Evox will use its proprietary technology platform to modify and load RNA and protein drugs into exosomes and target the […]

March 27, 2020 - 3 minutesmins - By Laura Cowen

valo therapeutics oxford finland cancer immunotherapy

Startup Scout 27 Mar 2020

This Startup is Making a Cancer Vaccine out of Viruses

Valo Therapeutics is operating both in the UK and Finland to develop a cancer vaccine based on a virus designed to kill tumors. Mission: To combine two different immunotherapy techniques — oncolytic viruses and cancer vaccines — into one treatment for solid tumors. Immunotherapy has transformed the cancer treatment landscape, offering therapies such as checkpoint […]

March 27, 2020 - 4 minutesmins - By Jonathan Smith

News and Trends 26 Mar 2020

Silence Therapeutics to Work with AstraZeneca in RNAi Deal Worth up to €3.6B

AstraZeneca is recruiting RNAi specialist Silence Therapeutics to develop treatments for cardiovascular, renal, metabolic, and respiratory diseases. RNA interference, or RNAi, is a relatively new field of medicine in which therapeutic small interfering (si)RNA molecules — known as siRNA molecules — can selectively block genes and thus inhibit the production of disease-causing proteins. John Strafford, […]

March 26, 2020 - 3 minutesmins - By Laura Cowen

News and Trends 26 Mar 2020

Novacyt Launches Two-Hour Coronavirus Test After FDA Approval

The French clinical diagnostics specialist Novacyt has announced FDA authorization for its fast and easily transportable test for the coronavirus disease COVID-19. The company is also rolling out the kit this week via manufacturing and distribution partnerships across Europe. The test received an Emergency Use Authorization from the FDA, which means it can only be […]

March 26, 2020 - 3 minutesmins - By External Contributor

News and Trends 25 Mar 2020

DBV Technologies’ Peanut Allergy Treatment Hits FDA Setback

French biotech DBV Technologies’ bid for the US approval of a skin patch to treat nut allergies could be delayed as the FDA requested more information on the patch’s efficacy. Specifically, the FDA requested more information on patch-site adhesion – critical to the patch working effectively – as well as its long-term efficacy. According to […]

March 25, 2020 - 3 minutesmins - By External Contributor

alzheimers disease phase iii UK 1 e1557338331863

News and Trends 24 Mar 2020

Eli Lilly Sweetens AC Immune Alzheimer’s Treatment Deal by €38M

A deal between Swiss biotech AC Immune and Eli Lilly to develop an oral Alzheimer’s disease drug has increased in worth by €38M with a new milestone payment. AC Immune and Eli Lilly modified a deal signed in late 2018 to co-develop a small molecule treatment to slow the progression of Alzheimer’s disease. Specifically, the […]

March 24, 2020 - 3 minutesmins - By Jonathan Smith

moderna biontech personalized cancer vaccine

News and Trends 24 Mar 2020

Vaccitech’s Prostate Cancer Vaccine Shows Promise in Phase II

The UK immunotherapy company Vaccitech has announced promising initial results from a phase IIa trial of a therapeutic vaccine that could offer a new way to treat advanced prostate cancer. In the open-label trial, the University of Oxford spin-off enrolled 23 patients with advanced castration-resistant prostate cancer. The patients received the company’s viral vector vaccine […]

March 24, 2020 - 2 minutesmins - By Anita Chakraverty

News and Trends 23 Mar 2020

ViiV Healthcare’s Monthly HIV Injection Gains First Approval in Canada

A monthly two-drug injection developed by the GSK spinoff ViiV Healthcare has been approved for the treatment of HIV in Canada, which could replace the need for daily antiretroviral pills. The treatment — branded as Cabenuva and developed in collaboration with Janssen — was approved by Health Canada to suppress HIV in adults with stable […]

March 23, 2020 - 2 minutesmins - By Jonathan Smith

Interview 23 Mar 2020

Riding the Wave of Cambridge Entrepreneurship

The University of Cambridge is world-famous, but unlike its US equivalent, the city isn’t as well known for its startup culture. Jason Mellad, CEO of StartCodon — a new accelerator based there — believes the area is a great place to set up a new biotech. “When I arrived in 2004, there were several people, […]

March 23, 2020 - 9 minutesmins - By Helen Albert

News and Trends 20 Mar 2020

Themis and Institut Pasteur Join Coronavirus Vaccine Hunt

The Austrian biotech Themis — specializing in vaccines for infectious and insect-borne diseases — has jumped on the coronavirus vaccine bandwagon along with the Institut Pasteur and other international partners. The collaboration will be led by the Parisian Institut Pasteur, whose vaccine technology — in this case modifying a measles virus vector to carry coronavirus […]

March 20, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 19 Mar 2020

Labiotech.eu’s Coverage of the Covid-19 Coronavirus

Like many others, the biopharma industry has been shaken by the rapid rise of the coronavirus outbreak. But unlike any other industry, biopharma can solve the growing threat through science and innovation. Our journalists are working hard to deliver as much information as possible on the current crisis. If quality information and independent journalism also […]

March 19, 2020 - 13 minutesmins - By Joachim Eeckhout

News and Trends 18 Mar 2020

OncoOne Raises €13M Series A to Develop First-in-Class Cancer Treatments

Austrian startup OncoOne has closed its first round of venture capital funding after raising €13M to investigate a new treatment target against solid tumor cancers. Investment in the Series A funding included public grants from the Austrian Research Promotion Agency and the promotional bank of the Austrian federal government, the Austria Wirtschaftsservice Gesellschaft, along with […]

March 18, 2020 - 2 minutesmins - By Anita Chakraverty

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Evox Therapeutics Receives up to €800M from Takeda To Tackle Rare Diseases

This Startup is Making a Cancer Vaccine out of Viruses

Silence Therapeutics to Work with AstraZeneca in RNAi Deal Worth up to €3.6B

Novacyt Launches Two-Hour Coronavirus Test After FDA Approval

DBV Technologies’ Peanut Allergy Treatment Hits FDA Setback

Eli Lilly Sweetens AC Immune Alzheimer’s Treatment Deal by €38M

Vaccitech’s Prostate Cancer Vaccine Shows Promise in Phase II

ViiV Healthcare’s Monthly HIV Injection Gains First Approval in Canada

Riding the Wave of Cambridge Entrepreneurship

Themis and Institut Pasteur Join Coronavirus Vaccine Hunt

Labiotech.eu’s Coverage of the Covid-19 Coronavirus

OncoOne Raises €13M Series A to Develop First-in-Class Cancer Treatments

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!